Wockhardt reports consolidated net loss of Rs92.79cr in Q4


Wockhardt recorded a consolidated net loss of Rs92.79cr in the quarter ended March 2021 as against a net profit of Rs48.29cr during the previous quarter ended March 2020.

The revenue declined 8% to Rs631.96cr in the quarter ended March 2021 as against Rs686.93cr during the previous quarter ended March 2020.

Wockhardt Ltd ended at Rs675 down by Rs110.95 or 14.12% from its previous closing of Rs785.95 on the BSE.

Business Review:


  • UK Business during the quarter stood at Rs261crore in Q4FY21 (PY Rs.229 crore) showing a growth of 14%. UK Business contributed about 41% of Global Revenue. Major growth has come from the COVID-19 Vaccine business ~5mn GBP.

  • Emerging Markets Business of the Company stood at Rs121cr in Q4FY21 (PY Rs133cr). Emerging Markets Business contributed about 19% of the Global Revenue.

  • India Business (both Continued and Discontinued Operations) stood at Rs118cr in Q4FY21 as compared to Rs177cr in Q4FY20. The Continuing Business stood at Rs120 in Q4FY21 (PY Rs74cr) registering a growth of 63%. India Business contributed 19% of the Global Revenue.

  • Irish Business stood at Rs32cr in Q4FY21 (PY Rs38cr).

  • US Business stood at Rs95cr in Q4FY21 as compared to Rs189cr in Q4FY20. US Business contributed 15% of the Global Revenue.

  • Research and Development expenditure during the quarter was at Rs48cr (8% to sales) and including capital expenditure was at 11% to sales. Capital expenditure during the quarter was Rs22cr.


Wockhardt Ltd ended at Rs675, down by Rs110.95 or 14.12% from its previous closing of Rs785.95 on the BSE.

Related Story



Related Tags:





#Wockhardt #reports #consolidated #net #loss #Rs9279cr

( With inputs from indiainfoline)